[1] |
BECKER JU, SERON D, RABANT M, et al. Evolution of the definition of rejection in kidney transplantation and its use as an endpoint in clinical trials[J]. Transpl Int, 2022, 35: 10141. DOI: 10.3389/ti.2022.10141.
|
[2] |
FATTHY M, SALEH A, AHMED RA, et al. Incidence and determinants of complications of percutaneous kidney biopsy in a large cohort of native kidney and kidney transplant recipients[J]. Sultan Qaboos Univ Med J, 2022, 22(2): 268-273. DOI: 10.18295/squmj.5.2021.107.
|
[3] |
SIDHU PS, CANTISANI V, DIETRICH CF, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version)[J]. Ultraschall Med, 2018, 39(2): e2-e44. DOI: 10.1055/a-0586-1107.
|
[4] |
ZHANG L, LIN Z, ZENG L, et al. Ultrasound-induced biophysical effects in controlled drug delivery[J]. Sci China Life Sci, 2022, 65(5): 896-908. DOI: 10.1007/s11427-021-1971-x.
|
[5] |
GRANATA A, CAMPO I, LENTINI P, et al. Role of contrast-enhanced ultrasound (CEUS) in native kidney pathology: limits and fields of action[J]. Diagnostics (Basel), 2021, 11(6): 1058. DOI: 10.3390/diagnostics11061058.
|
[6] |
LI Q, YANG K, JI Y, et al. Safety analysis of adverse events of ultrasound contrast agent Lumason/SonoVue in 49, 100 patients[J]. Ultrasound Med Biol, 2023, 49(2): 454-459. DOI: 10.1016/j.ultrasmedbio.2022.09.014.
|
[7] |
MORGAN TA, JHA P, PODER L, et al. Advanced ultrasound applications in the assessment of renal transplants: contrast-enhanced ultrasound, elastography, and B-flow[J]. Abdom Radiol (NY), 2018, 43(10): 2604-2614. DOI: 10.1007/s00261-018-1585-1.
|
[8] |
MUELLER-PELTZER K, NEGRÃO DE FIGUEIREDO G, FISCHEREDER M, et al. Vascular rejection in renal transplant: diagnostic value of contrast-enhanced ultrasound (CEUS) compared to biopsy[J]. Clin Hemorheol Microcirc, 2018, 69(1/2): 77-82. DOI: 10.3233/CH-189115.
|
[9] |
HAI Y, CHONG W, LIU JB, et al. The diagnostic value of contrast-enhanced ultrasound for monitoring complications after kidney transplantation-a systematic review and meta-analysis[J]. Acad Radiol, 2021, 28(8): 1086-1093. DOI: 10.1016/j.acra.2020.05.009.
|
[10] |
LERCHBAUMER MH, FISCHER T, ULUK D, et al. Diagnostic value of contrast-enhanced ultrasound (CEUS) in kidney allografts - 12 years of experience in a tertiary referral center[J]. Clin Hemorheol Microcirc, 2022, 82(1): 75-83. DOI: 10.3233/CH-211357.
|
[11] |
SELBY NM, WILLIAMS JP, PHILLIPS BE. Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases[J]. Curr Opin Nephrol Hypertens, 2021, 30(1): 138-143. DOI: 10.1097/MNH.0000000000000664.
|
[12] |
GOYAL A, HEMACHANDRAN N, KUMAR A, et al. Evaluation of the graft kidney in the early postoperative period: performance of contrast-enhanced ultrasound and additional ultrasound parameters[J]. J Ultrasound Med, 2021, 40(9): 1771-1783. DOI: 10.1002/jum.15557.
|
[13] |
VIČIČ E, KOJC N, HOVELJA T, et al. Quantitative contrast-enhanced ultrasound for the differentiation of kidney allografts with significant histopathological injury[J]. Microcirculation, 2021, 28(8): e12732. DOI: 10.1111/micc.12732.
|
[14] |
KIM DG, LEE JY, AHN JH, et al. Quantitative ultrasound for non-invasive evaluation of subclinical rejection in renal transplantation[J]. Eur Radiol, 2023, 33(4): 2367-2377. DOI: 10.1007/s00330-022-09260-x.
|
[15] |
FRIEDL S, JUNG EM, BERGLER T, et al. Factors influencing the time-intensity curve analysis of contrast-enhanced ultrasound in kidney transplanted patients: toward a standardized contrast-enhanced ultrasound examination[J]. Front Med (Lausanne), 2022, 9: 928567. DOI: 10.3389/fmed.2022.928567.
|
[16] |
AGGARWAL A, GOSWAMI S, DAS CJ. Contrast-enhanced ultrasound of the kidneys: principles and potential applications[J]. Abdom Radiol (NY), 2022, 47(4): 1369-1384. DOI: 10.1007/s00261-022-03438-z.
|
[17] |
DAVID E, DEL GAUDIO G, DRUDI FM, et al. Contrast enhanced ultrasound compared with MRI and CT in the evaluation of post-renal transplant complications[J]. Tomography, 2022, 8(4): 1704-1715. DOI: 10.3390/tomography8040143.
|
[18] |
ELEC FI, MOISOIU T, SOCACIU MA, et al. Difficulties in diagnosing HIV-associated nephropathy in kidney transplanted patients. the role of ultrasound and CEUS[J]. Med Ultrason, 2020, 22(4): 488-491. DOI: 10.11152/mu-2314.
|
[19] |
KHODABAKHSHI Z, HOSSEINKHAH N, GHADIRI H. Pulsating microbubble in a micro-vessel and mechanical effect on vessel wall: a simulation study[J]. J Biomed Phys Eng, 2021, 11(5): 629-640. DOI: 10.31661/jbpe.v0i0.1131.
|
[20] |
LUKÁČ R, KAUEROVÁ Z, MAŠEK J, et al. Preparation of metallochelating microbubbles and study on their site-specific interaction with rGFP-HisTag as a model protein[J]. Langmuir, 2011, 27(8): 4829-4837. DOI: 10.1021/la104677b.
|
[21] |
KLIBANOV AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging[J]. Bioconjug Chem, 2005, 16(1): 9-17. DOI: 10.1021/bc049898y.
|
[22] |
GRABNER A, KENTRUP D, PAWELSKI H, et al. Renal contrast-enhanced sonography findings in a model of acute cellular allograft rejection[J]. Am J Transplant, 2016, 16(5): 1612-1619. DOI: 10.1111/ajt.13648.
|
[23] |
LIU J, CHEN Y, WANG G, et al. Ultrasound molecular imaging of acute cardiac transplantation rejection using nanobubbles targeted to T lymphocytes[J]. Biomaterials, 2018, 162: 200-207. DOI: 10.1016/j.biomaterials.2018.02.017.
|
[24] |
XIE Y, CHEN Y, ZHANG L, et al. Ultrasound molecular imaging of lymphocyte-endothelium adhesion cascade in acute cellular rejection of cardiac allografts[J]. Transplantation, 2019, 103(8): 1603-1611. DOI: 10.1097/TP.0000000000002698.
|
[25] |
郝军军, 郭锋伟. 补体C4d、高敏C反应蛋白及肾移植术后Th1、Th2水平与排斥反应的相关性[J]. 中国临床研究, 2022, 35(10): 1356-1360, 1365. DOI: 10.13429/j.cnki.cjcr.2022.10.005.HAO JJ, GUO FW. Associations of complement C4d, hs-CRP and Th1, Th2 levels with rejection after renal transplantation[J]. Chin J Clin Res, 2022, 35(10): 1356-1360, 1365. DOI: 10.13429/j.cnki.cjcr.2022.10.005.
|
[26] |
LIAO T, ZHANG Y, REN J, et al. Noninvasive quantification of intrarenal allograft C4d deposition with targeted ultrasound imaging[J]. Am J Transplant, 2019, 19(1): 259-268. DOI: 10.1111/ajt.15105.
|
[27] |
LIAO T, LIU X, REN J, et al. Noninvasive and quantitative measurement of C4d deposition for the diagnosis of antibody-mediated cardiac allograft rejection[J]. EBioMedicine, 2018, 37: 236-245. DOI: 10.1016/j.ebiom.2018.10.061.
|
[28] |
HAAS M, LOUPY A, LEFAUCHEUR C, et al. The Banff 2017 Kidney Meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials[J]. Am J Transplant, 2018, 18(2): 293-307. DOI: 10.1111/ajt.14625.
|
[29] |
邹孝猛, 毛盈譞, 张羽, 等. 超声靶向微泡破坏实现肿瘤递药研究进展[J]. 中国医学影像技术, 2022, 38(11): 1739-1742. DOI: 10.13929/j.issn.1003-3289.2022.11.033.ZOU XM, MAO YX, ZHANG Y, et al. Progresses of ultrasound targeted microbubble destruction for antineoplastic drug delivery[J]. Chin J Med Imag Technol, 2022, 38(11): 1739-1742. DOI: 10.13929/j.issn.1003-3289.2022.11.033.
|
[30] |
许涛, 周畅. 靶向微泡介导超声辅助溶栓技术研究进展[J]. 实用医学杂志, 2022, 38(10): 1187-1192. DOI: 10.3969/j.issn.1006-5725.2022.10.003.XU T, ZHOU C. Progress in targeted microbubble mediated ultrasound assisted thrombolysis[J]. J Pract Med, 2022, 38(10): 1187-1192. DOI: 10.3969/j.issn.1006-5725.2022.10.003.
|
[31] |
XIA H, YANG D, HE W, et al. Ultrasound-mediated microbubbles cavitation enhanced chemotherapy of advanced prostate cancer by increasing the permeability of blood-prostate barrier[J]. Transl Oncol, 2021, 14(10): 101177. DOI: 10.1016/j.tranon.2021.101177.
|
[32] |
LIAO T, LI Q, ZHANG Y, et al. Precise treatment of acute antibody-mediated cardiac allograft rejection in rats using C4d-targeted microbubbles loaded with nitric oxide[J]. J Heart Lung Transplant, 2020, 39(5): 481-490. DOI: 10.1016/j.healun.2020.02.002.
|
[33] |
LIU J, CHEN Y, WANG G, et al. Improving acute cardiac transplantation rejection therapy using ultrasound-targeted FK506-loaded microbubbles in rats[J]. Biomater Sci, 2019, 7(9): 3729-3740. DOI: 10.1039/c9bm00301k.
|
[34] |
LUO Z, JI Y, ZHOU H, et al. Galectin-7 in cardiac allografts in mice: increased expression compared with isografts and localization in infiltrating lymphocytes and vascular endothelial cells[J]. Transplant Proc, 2013, 45(2): 630-634. DOI: 10.1016/j.transproceed.2012.12.005.
|
[35] |
ZLATEV I, CASTORENO A, BROWN CR, et al. Reversal of siRNA-mediated gene silencing in vivo[J]. Nat Biotechnol, 2018, 36(6): 509-511. DOI: 10.1038/nbt.4136.
|
[36] |
ALSHAER W, ZUREIGAT H, AL KARAKI A, et al. siRNA: mechanism of action, challenges, and therapeutic approaches[J]. Eur J Pharmacol, 2021, 905: 174178. DOI: 10.1016/j.ejphar.2021.174178.
|
[37] |
PAUNOVSKA K, LOUGHREY D, DAHLMAN JE. Drug delivery systems for RNA therapeutics[J]. Nat Rev Genet, 2022, 23(5): 265-280. DOI: 10.1038/s41576-021-00439-4.
|
[38] |
WANG Z, JIANG S, LI S, et al. Targeted galectin-7 inhibition with ultrasound microbubble targeted gene therapy as a sole therapy to prevent acute rejection following heart transplantation in a rodent model[J]. Biomaterials, 2020, 263: 120366. DOI: 10.1016/j.biomaterials.2020.120366.
|